GHP Investment Advisors’s ZimVie ZIMV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-15
| Closed | -$285 | – | 1014 |
|
|
2025
Q3 | $285 | Hold |
15
| – | – | ﹤0.01% | 917 |
|
|
2025
Q2 | $141 | Hold |
15
| – | – | ﹤0.01% | 933 |
|
|
2025
Q1 | $162 | Hold |
15
| – | – | ﹤0.01% | 937 |
|
|
2024
Q4 | $210 | Sell |
15
-9
| -38% | -$129 | ﹤0.01% | 962 |
|
|
2024
Q3 | $381 | Hold |
24
| – | – | ﹤0.01% | 940 |
|
|
2024
Q2 | $438 | Sell |
24
-1
| -4% | -$16 | ﹤0.01% | 931 |
|
|
2024
Q1 | $413 | Hold |
25
| – | – | ﹤0.01% | 808 |
|
|
2023
Q4 | $444 | Hold |
25
| – | – | ﹤0.01% | 812 |
|
|
2023
Q3 | $206 | Sell |
25
-53
| -68% | -$612 | ﹤0.01% | 917 |
|
|
2023
Q2 | $936 | Hold |
78
| – | – | ﹤0.01% | 879 |
|
|
2023
Q1 | $564 | Hold |
78
| – | – | ﹤0.01% | 881 |
|
|
2022
Q4 | $729 | Sell |
78
-16
| -17% | -$140 | ﹤0.01% | 881 |
|
|
2022
Q3 | $1K | Sell |
94
-31
| -25% | -$500 | ﹤0.01% | 886 |
|
|
2022
Q2 | $2K | Sell |
125
-7
| -5% | -$154 | ﹤0.01% | 868 |
|
|
2022
Q1 | $3K | Buy |
+132
| New | +$3.11K | ﹤0.01% | 872 |
|
Other funds holding ZIMV
GHP Investment Advisors's ZIMV Position: Q4 2025 in Review
GHP Investment Advisors sold out of ZimVie (ZIMV) in Q4 2025, closing a stake of 15 shares — an estimated $285 sold.
GHP Investment Advisors first reported a position in ZIMV in Q1 2022 and held it in 15 quarters. The position peaked at $3K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZIMV as of Q4 2025.
- GHP Investment Advisors reported no remaining ZimVie position as of Q4 2025 after selling out during the quarter.
- GHP Investment Advisors sold 15 ZimVie shares in Q4 2025, an estimated $285.
- GHP Investment Advisors first reported a position in ZimVie in Q1 2022 and held it in 15 quarters.
- GHP Investment Advisors's ZimVie position peaked at $3K in Q1 2022.
- 1 fund tracked by Wall St. Rank held ZimVie as of Q4 2025.
Based on GHP Investment Advisors's 13F filing for Q4 2025, filed 27 Jan 2026.